Nectar Lifescience Ltd.
| BSE: 532649 | Sector: Health care |
| NSE: NECLIFE | ISIN Code: INE023H01027 |
| BSE 00:00 | 18 Oct | 30.35 |
-0.05 (-0.16%) |
OPEN
30.35 |
HIGH
30.85 |
LOW
30.30 |
| NSE 00:00 | 18 Oct | 30.35 |
-0.05 (-0.16%) |
OPEN
30.40 |
HIGH
31.00 |
LOW
30.25 |
| OPEN | 30.35 |
| PREVIOUS CLOSE | 30.40 |
| VOLUME | 30425 |
| 52-Week high | 48.40 |
| 52-Week low | 16.20 |
| P/E | |
| Mkt Cap.(Rs cr) | 681 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Nectar Lifescience Ltd. (NECLIFE) - Cash Flow
| Figures in Rs crore | 2021 | 2020 | 2019 |
| Opening Cash & Cash Equivalents | 21.23 | 20.58 | 8.91 |
| Net Cash From Operating Activities | 21.33 | 285.65 | 238.89 |
| Net Cash Used In/from Investing Activities | -28.62 | -33.14 | -26.13 |
| Net Cash Used In/from Financing Activities | 11.49 | -251.87 | -201.09 |
| Net (decrease)/increase In Cash and Cash Equivalents |
4.20 | 0.65 | 11.67 |
| Closing Cash & Cash Equivalents | 25.43 | 21.23 | 20.58 |
Quick Links for Nectar Lifescience:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
